Pulmonary manifestations in monkeypox pneumonia: A possible but little mentioned clinical issue

Lung disease is a significant medical condition. Lung issues are a typical clinical sign of many illnesses. Several infectious diseases are currently creating concern. The re-emergence of viral infections such as monkeypox will be the most serious concern in 2023. Pox is a potentially dangerous infection that affects almost everyone and results in an acute illness with dermatological signs. The most well-known human pox infections are pox, smallpox, and chickenpox. In addition to the well-known pox infections, emerging zoonotic pox infections have emerged as an intriguing new issue in infectious medicine.1 Since the middle of May 2022, WHO has received reports of monkeypox cases from three separate WHO zones, all of which are not endemic for monkeypox. Despite continuous epidemiological studies, no incidents have been connected to endemic locations. According to current data, the majority of cases have been detected among men who have sex with men seeking care in primary care and sexual health clinics. As a result, monkeypox has sparked the interest of people all around the world. At present, monkeypox has spread over Europe, posing a serious public health threat.2 The condition is often characterized by an acute febrile fever with a rash. Atypical presentation is possible; however, pneumonia may be the first symptom, and diagnosis may be delayed or overlooked if the practitioner fails to recognize it. In this brief editorial, the writers discuss the pulmonary manifestations of monkeypox. For an accurate and timely diagnosis, a full grasp of the clinical indications of monkeypox is essential. According to the authors of this article, pneumonia is a symptom of monkeypox. Pulmonary issues are a common clinical sign of many new diseases. In human situations, there is a scarcity of evidence.1 In a nonhuman monkey model, fluorine-18 fluorodeoxyglucose ((18)FDG) absorption was revealed to be a measure of inflammation in the lungs.3 The virus can be discovered in the lungs of infected animals.4 A lung disease may exist in people; however, it is typically overshadowed by a visible cutaneous lesion.1 Interstitial pneumonia is the most frequent type of pneumonia, which is difficult to distinguish from other types of viral pneumonia, but there are usually only modest respiratory symptoms.1 According to recent data from human cases in the United States,5 upper respiratory symptoms occurred at a high frequency (80%) among people. There is no progression to severe respiratory distress in this case series.5 Indeed, the respiratory issue in monkeypox is frequently overlooked. Respiratory symptoms are nearly always accompanied by a complication, such as bronchopneumonia.6 This could be because of the nature of "walking pneumonia," as previously indicated. Respiratory distress is a common problem seen in many respiratory viral infections. Although monkeypox is not a respiratory virus, it might also be able to induce respiratory distress. Complications and sequelae were observed to be more common in unvaccinated patients than in vaccinated patients. Patients with pulmonary distress have been observed, generally late in the course of illness, indicating secondary infection of the lungs.6 Pulmonary effusion is a common problem in many lung infections. Since monkeypox can involve the lung, pulmonary effusion is a possible clinical problem. In the animal model, the infected animals can develop lung effusion, including hemorrhagic effusion, as a possible complication of monkeypox.7 Additionally, pulmonary edema and pulmonary hemorrhage are also observed in animal models.8 However, in human cases, these clinical lung disorders are not reported. In conclusion, monkeypox is likely to appear for the first time in uncommon issues. Because a large-scale pandemic is currently a possibility, practitioners must be aware of the risk of monkeypox lung disease. Lung disorder is one of the many uncommon clinical problems of monkeypox, and early detection allows for early diagnosis and treatment. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.